Hi David and welcome.
Although you are right re: increasing membership but I am always very pleased when someone newly diagnosed finds us so quickly.
No one can prevent the development of CML (well not for the foreseeable future anyway) so numbers will inevitably go on increasing. However, over the last 2 decades we have seen the development of some pretty spectacular innovative therapy, and since 2000 access to those therapies has changed the prognosis of chronic phase CML.
Olivia is right, give yourself time to adjust to this. You are quite young to be diagnosed with this disease, but you are by no means unusual.
Currently there are several options for 1st line therapy - both 1st (imatinib/glivec) and 2nd generation (nilotinib/Tasigna- dasatinib/Sprycel) TKIs are on offer as first line and 2nd line treatment through the NHS.
(*Owing to cost, dasatinib/Sprycel is not approved for use in newly diagnosed but nevertheless it can be accessed through an application- by your doctor- to the cancer drugs fund.)
If you have not done so already then take a look at the first couple of articles on the Home Page- this might help you get your head around the current thinking of expert clinicians regarding how best to ensure a successful long term outcome with TKI therapy.
There is also the option of enrolling in a Clinical Trial- -both ponatinib and bosutinib two even newer candidate TKis, can be accessed in this way. Being in a clinical trial has other benefits to do with close monitoring of your response to therapy.
There is also the possibility of stem cell transplant if you have a suitably matched donor- although this is more challenging to say the least, but some do prefer or need to take that route.
As you are in London you have a good choice of expert CML centres.
Where are you being treated?
Please ask if you need any help with anything at all related to CML and the options open to you for 1st line therapy currently available in the UK.
Take your time with the clinical stuff - it is definitely worth teaching yourself about but that will take a while- and take a look at the video interviews with CML patients-
Glad you found us.
Sandy